A detailed history of Cwm, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 6,060 shares of SAGE stock, worth $34,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,060
Previous 849 613.78%
Holding current value
$34,723
Previous $9,000 388.89%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$7.02 - $13.08 $36,581 - $68,159
5,211 Added 613.78%
6,060 $44,000
Q2 2024

Jul 09, 2024

BUY
$10.58 - $17.9 $4,581 - $7,750
433 Added 104.09%
849 $9,000
Q1 2024

Apr 05, 2024

SELL
$18.62 - $26.95 $55 - $80
-3 Reduced 0.72%
416 $8,000
Q4 2023

Feb 01, 2024

SELL
$17.1 - $22.26 $13,440 - $17,496
-786 Reduced 65.23%
419 $9,000
Q3 2023

Oct 11, 2023

BUY
$16.75 - $48.98 $14,790 - $43,249
883 Added 274.22%
1,205 $25,000
Q2 2023

Aug 03, 2023

BUY
$40.65 - $59.54 $5,325 - $7,799
131 Added 68.59%
322 $15,000
Q1 2023

Apr 28, 2023

BUY
$37.27 - $46.57 $6,000 - $7,497
161 Added 536.67%
191 $8,000
Q2 2022

Jul 28, 2022

SELL
$27.52 - $37.99 $908 - $1,253
-33 Reduced 52.38%
30 $1,000
Q1 2022

Apr 21, 2022

BUY
$30.71 - $45.71 $1,504 - $2,239
49 Added 350.0%
63 $2,000
Q4 2019

Sep 14, 2021

SELL
$60.18 - $154.77 $1,263 - $3,250
-21 Reduced 60.0%
14 $1,000
Q4 2019

Jan 27, 2020

BUY
$60.18 - $154.77 $1,263 - $3,250
21 Added 150.0%
35 $3,000
Q3 2019

Sep 14, 2021

BUY
$140.29 - $189.96 $1,122 - $1,519
8 Added 133.33%
14 $1,000
Q3 2019

Oct 22, 2019

SELL
$140.29 - $189.96 $1,122 - $1,519
-8 Reduced 57.14%
6 $1,000
Q2 2019

Sep 14, 2021

BUY
$157.85 - $183.09 $1,262 - $1,464
8 Added 133.33%
14 $1,000
Q2 2019

Jul 31, 2019

SELL
$157.85 - $183.09 $1,262 - $1,464
-8 Reduced 57.14%
6 $1,000
Q1 2019

Sep 02, 2021

BUY
$89.33 - $163.65 $446 - $818
5 Added 55.56%
14 $0
Q1 2019

Apr 22, 2019

BUY
$89.33 - $163.65 $267 - $490
3 Added 50.0%
9 $1,000
Q3 2017

Oct 16, 2017

BUY
$61.4 - $88.52 $368 - $531
6
6 $0

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.